SCYNEXIS
SCYX
#10067
Rank
HK$0.21 B
Marketcap
HK$5.10
Share price
-2.00%
Change (1 day)
-45.37%
Change (1 year)

Earnings for SCYNEXIS (SCYX)

Earnings in 2025 (TTM): -HK$0.2 Billion

According to SCYNEXIS's latest financial reports the company's current earnings are HK$2.93 Million. In 2024 the company made an earning of -HK$0.16 Billion a decrease over its 2023 earnings that were of HK$0.54 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for SCYNEXIS from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.2 Billion22.85%
2024 -HK$0.16 Billion-128.88%
2023 HK$0.54 B-212.84%
2022 -HK$0.49 Billion87.15%
2021 -HK$0.26 Billion-41.74%
2020 -HK$0.45 Billion8.41%
2019 -HK$0.42 Billion205.58%
2018 -HK$0.14 Billion-25.66%
2017 -HK$0.19 Billion-31.73%
2016 -HK$0.27 Billion19.9%
2015 -HK$0.23 Billion111.45%
2014 -HK$0.11 Billion-27.82%
2013 -HK$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Galmed Pharmaceuticals
GLMD
-HK$67.88 Million-64.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
KemPharm
KMPH
-HK$0.33 Billion 68.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-HK$0.71 Billion 265.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$2.22 B-1,248.09%๐Ÿ‡บ๐Ÿ‡ธ USA